What is the maximum dose of epinephrine (adrenaline) that can be administered via a peripheral intravenous line?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Maximum Epinephrine Dose via Peripheral IV Line

For continuous IV infusion of epinephrine through a peripheral line, the maximum rate is 10 mcg/min in adults, though doses as high as 5 mcg/kg/min have been used in pediatric shock states. 1, 2

Context-Dependent Dosing

The "maximum" dose varies dramatically based on clinical indication:

For Anaphylaxis (Non-Arrest)

  • IV bolus: 0.05-0.1 mg (50-100 mcg) slowly over several minutes 3
  • Continuous infusion: Start 1-4 mcg/min, titrate up to maximum 10 mcg/min for adults 1
  • Pediatric infusion: 0.1-1.0 mcg/kg/min, starting at lowest dose 2

For Shock/Hypotension (Post-Resuscitation)

  • Adult infusion: 0.05-2 mcg/kg/min per FDA labeling 4
  • Pediatric infusion: 0.1-1.0 mcg/kg/min, with doses up to 5 mcg/kg/min sometimes necessary 2

For Cardiac Arrest

  • Standard dose: 1 mg IV push every 3-5 minutes (no maximum number of doses) 3, 5
  • High-dose: 3-5 mg IV push, progressing to 4-10 mg/min infusion in refractory arrest 1
  • Pediatric: 0.01 mg/kg (max 1 mg) every 3-5 minutes 5

Critical Safety Considerations

The risk of potentially lethal arrhythmias means IV epinephrine should only be used during cardiac arrest or profound hypotension unresponsive to volume resuscitation and multiple IM doses. 1 This is the most important caveat—peripheral IV epinephrine is inherently high-risk outside these specific scenarios.

Monitoring Requirements

  • Continuous hemodynamic monitoring is essential when available 1
  • If formal monitoring unavailable but clinician deems IV epinephrine essential: every-minute blood pressure, pulse, and ECG monitoring 1
  • Watch for acute severe hypertension, arrhythmias, myocardial ischemia 4

Extravasation Risk

Peripheral IV infiltration causes severe tissue necrosis. 2 If extravasation occurs:

  • Inject phentolamine 0.1-0.2 mg/kg (up to 10 mg) diluted in 10 mL normal saline intradermally at the site 2
  • This counteracts dermal vasoconstriction

Preparation Standards

For continuous infusion via peripheral line:

  • Standard concentration: 1 mg in 250 mL D5W = 4 mcg/mL 1
  • Alternative: 1 mg in 100 mL saline = 10 mcg/mL (requires infusion pump) 1
  • Infuse into a large vein 4

Route Hierarchy

Intramuscular (IM) is strongly preferred over IV for anaphylaxis unless the patient is in cardiac arrest or profoundly hypotensive after failed IM doses and volume resuscitation. 1, 3 The anterolateral thigh (vastus lateralis) produces higher and more rapid peak levels than arm injection. 1

Common Pitfalls

  1. Using IV epinephrine too early in anaphylaxis: Multiple IM doses (0.3-0.5 mg every 5-15 min) should be exhausted first 3
  2. Inadequate monitoring: Even with peripheral access, continuous cardiac monitoring is non-negotiable
  3. Wrong concentration: Ensure 1:10,000 (0.1 mg/mL) for IV bolus vs 1:1,000 (1 mg/mL) for IM 2
  4. Ignoring extravasation: Check IV site frequently during infusion

There is no absolute maximum dose in cardiac arrest—resuscitation takes priority over theoretical toxicity concerns. 1, 3 However, for non-arrest indications via peripheral IV, staying at or below 10 mcg/min minimizes arrhythmia risk while maintaining therapeutic effect.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.